wayground logo

Free Printable Worksheets

NEW

Font size

S
M
L
XL
Worksheets

Therapeutic Drug Monitoring

Total questions: 20

Worksheet time: 10mins

Name
Class
Date
1.

Phenytoin gives toxic symptoms when the plasma conc. is greater than

a)

10 µg/mL.

b)

20 µg/mL

c)

30 µg/mL

d)

10 ng/mL

2.

The toxic range of digoxin is greater than

a)

2.5 ng/mL

b)

15.5 ng/mL

c)

25.5 ng/mL

d)

50 ng.mL

3.

Therapeutic range of digoxin is

a)

9.8-12.6ng/mL

b)

3.5-4.0 ng/mL

c)

0.8-2.0 ng/mL

d)

6.6-8.00 ng.mL

4.

Which is the ADR of Phenytoin?

a)

GI bleeding

b)

Red man syndrome

c)

Migraine

d)

Gingival hyperplasia

5.

Therapeutic range of cyclosporine?

a)

500 to 800 ng/mL

b)

100 to 400 ng/mL

c)

200 to 700 ng/mL

d)

500-1000 mcg/mL

6.

The sample collected prior to the administration of next dose is known as

a)

Peak sampling

b)

Trough sampling

c)

infinite conc. sampling

d)

None of the above

7.

To calculate Loading Dose, the parameter required is

a)

Ka

b)

Ke

c)

AUC

d)

Vd

8.

In TDM of cyclosporine, which biological matrix is used?

a)

Plasma

b)

Serum

c)

Saliva

d)

Whole blood

9.

1) TDM is a tool to individualize dosage regimen by maintaining plasma concentration within _______

a)

Dosing interval

b)

Minimum effective concentration

c)

Therapeutic range

d)

Ratio between MEC and MTC as 1:2

10.

In trough sampling, which is considered as good sampling time?

a)

Post dose sampling

b)

Pre dose sampling

c)

Both a & b

d)

None of the above

11.

Drug toxicity studies need

a)

Trough sample

b)

Peak sample

c)

Post dose trough sample

d)

Steady state plasma conc

12.

Therapeutic range of quinidine is

a)

3-8 mcg/mL

b)

4-6 mcg/mL

c)

5-15 mcg/mL

d)

10-15 mcg/mL

13.

The drug that follow non-linear pharmacokinetics is

a)

Theophylline

b)

Amiodarone

c)

Propranolol

d)

Phenytoin

14.

Choose the drug with shortest half-life

a)

Phenobarbital

b)

Phenytoin

c)

Amikacin

d)

Theophyllin

15.

In TDM of digoxin, sample may be collected ------hrs after drug administration

a)

0.5 hrs

b)

1 hr

c)

6 hrs

d)

24 hrs

16.

The action potential prolonging effect of quinidine is observed in the

a)

lower end of therapeutic range

b)

upper end of therapeutic range

c)

end of 4-5 biological half-life

d)

toxic range

17.

What is FPIA

a)

Fluorescence Phosphorescence ImmunogenicAgent

b)

Fluorescence Polarization Immuno Assay

c)

Fluorescence Phosphorescence Immuno Assay

d)

Fluorophore Polarization Immuno Assay

18.

TDM is important for quinidine due to the following reason

a)

The action potential prolonging effect

b)

Potential to cause arrhythmia of Torsade de pointes

c)

Significant inter patient variability in bioavailability

d)

All the above

19.

Hepatic metabolism of quinidine is induced by

a)

Phenytoin

b)

Ketoconazole

c)

Rifampicin

d)

Both a & c

20.

When quinidine is administered with the following drug, there is additive potassium channel blockade

a)

Phenytoin

b)

Rifampicin

c)

both a & b

d)

Erythromycin